Saudi Arabia’s Capital Market Authority (CMA) approved Almasane Alkobra Mining Company’s (AMAK) request for a capital increase through a rights issue on 5 October 2026. The authority stated that the proposed increase is valued at SAR 680 million. That amount describes the approved request; it is not a completed offering, a subscription commitment or cash already received by the company. The regulatory decision does not replace the corporate and offering steps that remain.

According to the CMA, eligibility will be limited to shareholders recorded by the Securities Depository Center at the close of the second trading day after the extraordinary general assembly that decides the capital increase. AMAK’s board will determine the date of that assembly later. The company will also determine the subscription price and the number of shares offered after trading closes on the day the assembly is held. The 5 October approval therefore does not set those details or provide a final investor timetable or per-share price.

The authority said the prospectus would be published and made available to the public at a later date. Its announcement also warned that approval of a rights-issue prospectus should not be treated as a recommendation or assurance that the investment is worthwhile. Regulatory review means the proposal has met applicable capital-market requirements; it does not guarantee future mine output, metal prices, company cash flow or investor returns. Those are separate commercial and market risks.

Economically, a rights issue gives existing shareholders an opportunity to acquire new shares under specified terms and can provide a company with an equity-financing channel. Still, the approved SAR 680 million scale alone does not show that AMAK will raise that sum. Investor participation, the offer price and actual proceeds can be confirmed only through later offering documents and a results announcement. This is an editorial explanation of the financing mechanism, not a claim about how AMAK will use any proceeds.

The SAR 680 million figure in this report belongs to the approval announced on 5 October. The final eligibility date, share count, price, subscription period, take-up rate and cash proceeds were not supplied in that announcement. Presenting any of those as settled facts before the later steps would be misleading. Readers and investors should review the prospectus, its risk factors and subsequent company disclosures when they become available to assess the transaction’s terms.